Perspective Therapeutics
The Senior Director, Regulatory CMC leads global Chemistry, Manufacturing, and Controls (CMC) regulatory strategy for radiopharmaceutical development programs and future commercial products. This role defines CMC regulatory approaches, oversees the authorship of Module 3 content, and directs health authority interactions related to radiochemistry and manufacturing across the portfolio. The senior expert partners with cross-functional teams to ensure regulatory readiness and translates complex global expectations into actionable guidance for the business.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Perspective Therapeutics.
Perspective Therapeutics didn’t post a salary, so this is our estimate from similar listings.
38% above the average for this role